Selective Quarantine Keeps the Economy Running

29 March 2020 by Levin

COVID-19

In South Korea, Japan, Singapore and Hong Kong, the coronavirus is under control without the widespread shutdowns of other countries. Factories, restaurants and shops are still open. Singapore has even kept its schools open.

They've used testing aggressively to identify cases — not only testing people who are so sick that they're hospitalized but also mild cases and even suspected cases. Rather than keeping millions of people home, tens of thousands of people who may have been exposed to confirmed cases, are quarantined at home.

https://www.npr.org/sections/goatsandsoda/2020/03/26/821688981/how-south-korea-reigned-in-the-outbreak-without-shutting-everything-down

What do you think?

You must be logged in to post a comment.

Comments

IdeaSpies @ 2020.03.29 3:21 PM
Thanks for your post. We've shared it to IdeaSpies Twitter. When you share it please tag @IdeaSpies so we can see and support it.

Excellent point re the importance of testing. We included it in this post about Singapore.

https://www.ideaspies.com/posts/why-singapores-coronavirus-response-has-worked

Related Posts

COVID-19

siRNA for Treatment of SARS-CoV-2

RNA interference in animals involves small double-stranded RNA molecules called siRNA. These molecules are valuable tools for studying single gene function in both in vivo and in vitro settings and are also considered a promising class of therapeutics. SiRNA delivery systems fall into two categories: viral and non-viral, including peptides, polymers, and lipids. Studies using synthetic or plasmid-encoded siRNA show its antiviral effects against various viruses, including SARS-CoV. Learn more about siRNA for Treatment of SARS-CoV-2: https://sars-cov-2.creative-biolabs.com/sirna-for-the-treatment-of-sars-cov2.htm

27 September 2023 by Creative Biol... 0 Comments

COVID-19

Vaccine factories in shipping containers

BioNTech, which co-developed a revolutionary mRNA covid-19 vaccine in partnership with Pfizer, hopes to revolutionise another area of pharmaceuticals: vaccine manufacturing. It is developing vaccine factories to sit inside a series of standard metal shipping containers, which it plans to send to parts of the world that lack their own vaccine-manufacturing capabilities-notably Africa. Each facility, BioNTech says, will be able to produce up to 60m doses of covid vaccines and other vaccines each year, and will cost "significantly less" than conventional factories. If so, this could be the future of drugmaking. https://www.economist.com/science-and-technology/biontech-plans-to-make-vaccines-in-shipping-containers/

18 February 2022 by IdeaSpies 0 Comments